Genetix Biotherapeutics
The Senior Director, Quality Operations provides strategic and operational leadership for commercial Quality Operations, overseeing external manufacturing, lot disposition, and quality governance across clinical and commercial-stage supply. This role ensures compliance with global regulatory requirements and company quality standards while partnering with cross-functional teams to maintain uninterrupted patient supply and inspection readiness. The position involves leading a high-performing team and driving continuous improvement within a virtual operating model.
Headquarters
Somerville, Massachusetts, United States
Company Size
1-10 employees
Founded
1993
Genetix Biotherapeutics, formerly bluebird bio, is a biotechnology company focused on developing and commercializing transformative one-time genetic therapies for patients with rare diseases, including sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. The company markets three FDA-approved therapies—LYFGENIA, ZYNTEGLO, and SKYSONA—which are designed to treat the underlying genetic cause of disease using the patient's own blood stem cells. As a privately held company, Genetix Biotherapeutics is focused on commercial execution, scaling patient access, and improving the treatment experience for patients and providers.
Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO
4 days ago
bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots
Sep 18, 2025
After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics
Sep 18, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genetix Biotherapeutics.
117% above the average for this role
Genetix Announces 2025 Commercial Performance Results and Outlines 2026 Strategic Priorities
1 week ago
Director, GMP QA Operations
Revolution Medicines
Associate Director, GMP Quality Assurance
Revolution Medicines
Director, Quality Assurance
Nurix
Quality Specialist Raw Material Disposition - Quality Raw Materials (GMP)
Evotec
Director/Senior Director of Quality Operations
8a7883d06ad77017016b233a8d273b44
Senior Specialist, Quality Assurance Lot Disposition
Bristol Myers Squibb